The Contribution of Jim Tananbaum to the Growth of Foresite Capital

Jim Tananbaum’s company Foresite Capital is dedicated to identifying and providing equity to emerging health leaders to help them grow into excellent businesses which yield long term impact and enduring value. Jim is the founder and chief executive officer of Foresite capital. Before Foresite Capital, Jim also co-founded two other pharmaceutical companies NASDAQ and GENZ which have seen immense growth in the past two decades.

Jim’s investment experience has grown steadily over the past several years. He was a founding partner of Prospect Venture Partners and Sierra Ventures where he helped in the investment practice of several healthcare services. Jim Tananbaum majored in math and electrical engineering science. He has always been passionate about bringing healthcare and science together and incorporating business into all this to achieve profitability. Jim is also known for his frequent collaboration with known academicians. He is passionate about working across different fields with different academicians and entrepreneurs to achieve growth and change in the field of learning sciences.

Foresite Capital Management links the best practices of growth investment with healthcare specialization. It invests in companies with disruptive, late-stage products and services in all sectors of healthcare including diagnostics, genomics and medical devices. Jim has led the investment in close to twenty-one successful healthcare companies including the ones mentioned above. Dr. Jim Tananbaum has served on the advisory boards and visiting committees to the Harvard-MIT HST program and the Yale school of engineering. Visit Research Gate for more info.

Foresite Capital’s largest investment currently is Intarcia which is a twice a year type 2 diabetes implant which helps patients to control their diabetes and the loss of weight. Jim believes that Intarcias product has the potential to impact Diabetes like the IUD has impacted birth control. Diabetes and obesity affect about 350 million people globally, and if the projections are right, the product should be launched in the United States by the end of 2017. Jim Tananbaum explains his company Foresite means understanding and harnessing healthcare’s future. He further explains that healthcare services often requires more time and capital to be successful. Jim is an academician at heart and loves learning and says this is what keeps him productive as an entrepreneur.